Biotech · Public company · Waltham, MA, US
Damora Therapeutics, Inc.
Ticker DMRA · SEC CIK 0001800315
Track this companyFree. Adds Damora Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials11 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline2
- DMR-001Phase 1 · Myeloproliferative Neoplasms (MPNs)ClinicalTrials.gov · fetched Nov 12, 2026
- RuxolitinibPhase 1 · Myeloproliferative Neoplasms (MPNs)ClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials1
- A Study to Evaluate DMR-001 in Participants With CALR-mutant Myeloproliferative NeoplasmsPHASE1 · RECRUITING · started Sep 1, 2026ClinicalTrials.gov NCT07849231 · fetched Nov 12, 2026
SEC filings12
- 10-Q · 10-QSEC EDGAR · filed Nov 4, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Aug 10, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jul 20, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jun 17, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed May 12, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed May 4, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Apr 20, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Mar 23, 2026 · fetched Nov 12, 2026
- 10-K · 10-KSEC EDGAR · filed Mar 19, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Mar 10, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Feb 11, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Feb 10, 2026 · fetched Nov 12, 2026